-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on AtriCure, Raises Price Target to $70

Benzinga·11/04/2026 10:04:14
Listen to the news
BTIG analyst Marie Thibault maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $63 to $70.